N

Nordhealth AS
OSE:NORDH

Watchlist Manager
Nordhealth AS
OSE:NORDH
Watchlist
Price: 37.5 NOK 0.27% Market Closed
Market Cap: 3B NOK
Have any thoughts about
Nordhealth AS?
Write Note

Intrinsic Value

The intrinsic value of one NORDH stock under the Base Case scenario is 190.35 NOK. Compared to the current market price of 37.5 NOK, Nordhealth AS is Undervalued by 80%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

NORDH Intrinsic Value
190.35 NOK
Undervaluation 80%
Intrinsic Value
Price
N
Worst Case
Base Case
Best Case

Valuation Backtest
Nordhealth AS

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for NORDH cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about NORDH?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Nordhealth AS

Provide an overview of the primary business activities
of Nordhealth AS.

What unique competitive advantages
does Nordhealth AS hold over its rivals?

What risks and challenges
does Nordhealth AS face in the near future?

Summarize the latest earnings call
of Nordhealth AS.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Nordhealth AS.

Provide P/S
for Nordhealth AS.

Provide P/E
for Nordhealth AS.

Provide P/OCF
for Nordhealth AS.

Provide P/FCFE
for Nordhealth AS.

Provide P/B
for Nordhealth AS.

Provide EV/S
for Nordhealth AS.

Provide EV/GP
for Nordhealth AS.

Provide EV/EBITDA
for Nordhealth AS.

Provide EV/EBIT
for Nordhealth AS.

Provide EV/OCF
for Nordhealth AS.

Provide EV/FCFF
for Nordhealth AS.

Provide EV/IC
for Nordhealth AS.

Show me price targets
for Nordhealth AS made by professional analysts.

What are the Revenue projections
for Nordhealth AS?

How accurate were the past Revenue estimates
for Nordhealth AS?

What are the Net Income projections
for Nordhealth AS?

How accurate were the past Net Income estimates
for Nordhealth AS?

What are the EPS projections
for Nordhealth AS?

How accurate were the past EPS estimates
for Nordhealth AS?

What are the EBIT projections
for Nordhealth AS?

How accurate were the past EBIT estimates
for Nordhealth AS?

Compare the revenue forecasts
for Nordhealth AS with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Nordhealth AS and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Nordhealth AS against its competitors.

Analyze the profit margins
(gross, operating, and net) of Nordhealth AS compared to its peers.

Compare the P/E ratios
of Nordhealth AS against its peers.

Discuss the investment returns and shareholder value creation
comparing Nordhealth AS with its peers.

Analyze the financial leverage
of Nordhealth AS compared to its main competitors.

Show all profitability ratios
for Nordhealth AS.

Provide ROE
for Nordhealth AS.

Provide ROA
for Nordhealth AS.

Provide ROIC
for Nordhealth AS.

Provide ROCE
for Nordhealth AS.

Provide Gross Margin
for Nordhealth AS.

Provide Operating Margin
for Nordhealth AS.

Provide Net Margin
for Nordhealth AS.

Provide FCF Margin
for Nordhealth AS.

Show all solvency ratios
for Nordhealth AS.

Provide D/E Ratio
for Nordhealth AS.

Provide D/A Ratio
for Nordhealth AS.

Provide Interest Coverage Ratio
for Nordhealth AS.

Provide Altman Z-Score Ratio
for Nordhealth AS.

Provide Quick Ratio
for Nordhealth AS.

Provide Current Ratio
for Nordhealth AS.

Provide Cash Ratio
for Nordhealth AS.

What is the historical Revenue growth
over the last 5 years for Nordhealth AS?

What is the historical Net Income growth
over the last 5 years for Nordhealth AS?

What is the current Free Cash Flow
of Nordhealth AS?

Discuss the annual earnings per share (EPS)
trend over the past five years for Nordhealth AS.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Nordhealth AS

Current Assets 28.4m
Cash & Short-Term Investments 22.2m
Receivables 5.4m
Other Current Assets 797k
Non-Current Assets 63.6m
Long-Term Investments 720k
PP&E 498k
Intangibles 61.6m
Other Non-Current Assets 743k
Current Liabilities 9m
Accounts Payable 1.5m
Accrued Liabilities 5.1m
Other Current Liabilities 2.4m
Non-Current Liabilities 136k
Other Non-Current Liabilities 136k
Efficiency

Earnings Waterfall
Nordhealth AS

Revenue
36.8m EUR
Cost of Revenue
-5.2m EUR
Gross Profit
31.7m EUR
Operating Expenses
-43m EUR
Operating Income
-11.4m EUR
Other Expenses
255k EUR
Net Income
-11.1m EUR

Free Cash Flow Analysis
Nordhealth AS

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

NORDH Profitability Score
Profitability Due Diligence

Nordhealth AS's profitability score is 30/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
Positive 1-Year Revenue Growth
Declining ROE
30/100
Profitability
Score

Nordhealth AS's profitability score is 30/100. The higher the profitability score, the more profitable the company is.

NORDH Solvency Score
Solvency Due Diligence

Nordhealth AS's solvency score is 78/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Short-Term Solvency
78/100
Solvency
Score

Nordhealth AS's solvency score is 78/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NORDH Price Targets Summary
Nordhealth AS

Wall Street analysts forecast NORDH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NORDH is 46.92 NOK with a low forecast of 46.46 NOK and a high forecast of 48.3 NOK.

Lowest
Price Target
46.46 NOK
24% Upside
Average
Price Target
46.92 NOK
25% Upside
Highest
Price Target
48.3 NOK
29% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for NORDH?

Click here to dive deeper.

Dividends

Nordhealth AS
does not pay dividends
Shareholder Yield

Current shareholder yield for NORDH is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Nordhealth AS

Country

Norway

Industry

Health Care

Market Cap

3B NOK

Dividend Yield

0%

Description

Nordhealth AS is a cloud-based healthcare software-as-a-service company. The company is headquartered in Molde, More Og Romsdal. The company went IPO on 2021-06-03. The firm's flagship products are Provet Cloud and Diarium, both cloud-based Practice Management Software for veterinarians and therapists, respectively. The Group serves over 7,000 clinics and hospitals located in over 25 countries. Nordhealth's mission is to build software that empowers healthcare professionals to improve patient care, increase efficiency and expand their business.

Contact

MORE OG ROMSDAL
Molde
Eikremsvingen 9
+4723111111

IPO

2021-06-03

Employees

189

Officers

Chief Executive Officer
Mr. Charles MacBain
Chief Financial Officer
Ms. Mari Laine
Chief Innovation Officer of Veterinary & Board Member
Mr. Janne Heikki Huttunen
CEO of the Therapy Business Unit
Mr. Karan Wallia

See Also

Discover More
What is the Intrinsic Value of one NORDH stock?

The intrinsic value of one NORDH stock under the Base Case scenario is 190.35 NOK.

Is NORDH stock undervalued or overvalued?

Compared to the current market price of 37.5 NOK, Nordhealth AS is Undervalued by 80%.

Back to Top